NCT06215612View on ClinicalTrials.gov

ctDNA and MRI Parameters in Head and Neck Cancer

NANot yet recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2030

Conditions

Head and Neck NeoplasmsCarcinoma, Squamous

Interventions

OTHER

Blood draw, MRI

Blood draw, MRI

All Listed Sponsors

lead

Franziska Eckert

OTHER

NCT06215612 - ctDNA and MRI Parameters in Head and Neck Cancer | Biotech Hunter | Biotech Hunter